by Sanat Khanna | May 12, 2026
Cell therapy manufacturing generates large volumes of process data – from sensors, bioreactors, quality controls and genomic assays. In many facilities, much of that data are collected for regulatory compliance rather than for process improvement – a pattern that...
by Laya Kiani | Dec 12, 2024
The convergence of tissue engineering, regenerative medicine (TERM) and artificial intelligence (AI) has ushered in a transformative era for the biomedical field. By leveraging machine learning (ML) and deep learning (DL), researchers can enhance cell culture...
by Stacey Johnson | Aug 28, 2023
In 2019, CCRM launched a new blog to explain products, processes, terms, technologies, techniques and much more related to developing and manufacturing cell and gene therapy products. As a contract development and manufacturing organization (CDMO), CCRM wanted to...
by Lisa Willemse | Jan 9, 2020
It’s no secret that biology is unpredictable, random and sometimes messy. This is precisely what gives living organisms their singularity and uncanny ability to adapt. But as important as these traits might be in a herd of elephants as they adapt to climate change or...
by Sowmya Viswanathan | Mar 28, 2019
In this month’s installment of the “Bioprocess and Bioanalytics” blog, we get part II from Drs. Robin Turner and James Piret on Raman spectroscopy and how this method can be utilized to tell us new information about cell therapy products. Both are Professors in the...
Comments